News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nagasaki University and Astellas Pharma Inc. (YPH.BE) Launch Collaborative Research for Screening New Anti-Dengue Virus Drugs for Neglected Tropical Diseases



3/21/2013 10:40:11 AM

NAGASAKI, Japan & TOKYO--(BUSINESS WIRE)--The Nagasaki University ("Nagasaki University"; Nagasaki, Japan; President: Shigeru Katamine) and Astellas Pharma Inc. ("Astellas")(TOKYO:4503)(President and CEO: Yoshihiko Hatanaka) today announced that they have signed a collaborative research agreement to discover new drugs for the treatment of neglected tropical diseases ("NTDs") caused by dengue virus. This is the second execution of a collaborative research agreement on NTDs after the Nagasaki University and Astellas signed the previous one to discover new drugs for the treatment of NTDs caused by protozoan parasites on November 12, 2012.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES